Celltrion Healthcare, Stock Price Up 1.1% at This Hour... '2 Consecutive Quarters of Surprise'

As of 12:33 PM on the 20th, Celltrion Healthcare is trading at 92,000 KRW, up 1.1% from the previous day. The trading volume is 1,070,699 shares, which is about 28.72% of the previous day's volume. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.

On May 18, Kiwoom Securities researcher Heo Hye-min stated, "Due to the mid-May additional indication approval of Remsima SC for IBD and the rising market share of Truxima in the U.S., strong performance is expected in the second half of the year." He set the target price for Celltrion Healthcare at 130,000 KRW.

Over the past five days, individual investors have net purchased 238,523 shares of Celltrion Healthcare, while foreigners and institutions have net purchased 180,727 shares and net sold 425,630 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.